We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Oxford surgeons have devised a course to train healthcare providers in Africa to effectively treat children with clubfoot in under resourced situations.
Oxford spinout Argonaut Therapeutics is developing cancer drugs which reprogram cancer cells to undergo the body’s natural process of cell death, shrinking tumours. The company will focus on treatments for colorectal cancer and lymphoma.
Genomics plc, a 2014 spinout company that is developing an integrated platform to uncover the relationships between genetic variation and human disease, has been appointed as Analysis Partner for the Genomics England Genomics Expert Network for Enterprises (GENE) Consortium.
One person in every 500 has Parkinson’s disease, with more than 127,000 people in the UK and around 10 million people globally diagnosed with the condition.
Snell Advanced Media Ltd (SAM) has engaged Isis Enterprise to support with managing portions of its Intellectual Property (IP) portfolio.
Oxford University Innovation, the University’s research and expertise commercialisation company, has appointed Dr Matt Perkins as its new Chief Executive Officer. Dr Perkins will commence his role in October 2016.
A new mental health Patient Reported Outcome Measure, developed at The University of Sheffield, is exclusively available from Clinical Outcomes at Oxford University Innovation.
University spinout OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.
A technology co-developed at the Universities of Oxford and Sao Paulo State University in Brazil will be commercialised by spinout OID (Oxford Impedance Diagnostics), offering the potential for ultrasensitive fast diagnostic tests for a range of diseases.
The fourth annual Oxford Technology Showcase was held on Wednesday 6th July at Oxford’s Saïd Business School. The event brought together experts and innovators from Oxford University, the Oxford University Hospital Trust and the Oxfordshire region. Over 300 investors, entrepreneurs, healthcare companies, researchers and clinicians attended.
